Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
2(15%)
Results Posted
17%(1 trials)
Terminated
1(8%)

Phase Distribution

Ph not_applicable
8
62%
Ph phase_3
3
23%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution11 total trials
Phase 3Large-scale testing
3(27.3%)
N/ANon-phased studies
8(72.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

13

all time

Status Distribution
Active(2)
Completed(6)
Terminated(2)
Other(3)

Detailed Status

Completed6
unknown3
Recruiting2
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
2
Success Rate
85.7%
Most Advanced
Phase 3

Trials by Phase

Phase 33 (27.3%)
N/A8 (72.7%)

Trials by Status

completed646%
recruiting215%
withdrawn18%
unknown323%
terminated18%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials

All 13 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
13